552 related articles for article (PubMed ID: 32089746)
1. Refining Cancer Management Using Integrated Liquid Biopsy.
Qiu J; Xu J; Zhang K; Gu W; Nie L; Wang G; Luo Y
Theranostics; 2020; 10(5):2374-2384. PubMed ID: 32089746
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
Hu T; Wolfram J; Srivastava S
Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy in Solid Malignancy.
Scarlotta M; Simsek C; Kim AK
Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
[TBL] [Abstract][Full Text] [Related]
4. The Different Facets of Liquid Biopsy: A Kaleidoscopic View.
Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C
Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226
[TBL] [Abstract][Full Text] [Related]
5. The Potential of Aptamer-Mediated Liquid Biopsy for Early Detection of Cancer.
Roy D; Pascher A; Juratli MA; Sporn JC
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070509
[TBL] [Abstract][Full Text] [Related]
6. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
[TBL] [Abstract][Full Text] [Related]
7. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
8. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
[TBL] [Abstract][Full Text] [Related]
10. Applications of liquid biopsies for cancer.
Mattox AK; Bettegowda C; Zhou S; Papadopoulos N; Kinzler KW; Vogelstein B
Sci Transl Med; 2019 Aug; 11(507):. PubMed ID: 31462507
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.
Roy D; Tiirikainen M
Trends Cancer; 2020 Feb; 6(2):78-81. PubMed ID: 32061307
[TBL] [Abstract][Full Text] [Related]
12. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsies in urological cancers: what we need to know before starting using them.
Franceschini T; Giunchi F; Montironi R; Scarpelli M; Lopez-Beltran A; Cheng L; Fiorentino M
Expert Rev Mol Diagn; 2020 Feb; 20(2):135-139. PubMed ID: 31509027
[No Abstract] [Full Text] [Related]
14. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
Giannopoulou L; Kasimir-Bauer S; Lianidou ES
Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsies.
Lianidou E; Pantel K
Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
17. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy for cancer screening, diagnosis, and treatment.
Smania MA
J Am Assoc Nurse Pract; 2020 Jan; 32(1):5-7. PubMed ID: 31913212
[TBL] [Abstract][Full Text] [Related]
19. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA.
van der Pol Y; Mouliere F
Cancer Cell; 2019 Oct; 36(4):350-368. PubMed ID: 31614115
[TBL] [Abstract][Full Text] [Related]
20. Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.
Schneegans S; Lück L; Besler K; Bluhm L; Stadler JC; Staub J; Greinert R; Volkmer B; Kubista M; Gebhardt C; Sartori A; Irwin D; Serkkola E; Af Hällström T; Lianidou E; Sprenger-Haussels M; Hussong M; Mohr P; Schneider SW; Shaffer J; Pantel K; Wikman H
Mol Oncol; 2020 May; 14(5):1001-1015. PubMed ID: 32246814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
